A mitotically active, cellular tumor stroma and/or inflammatory cells associated with tumor cells may contribute to intermediate or high Oncotype DX Recurrence Scores in low-grade invasive breast carcinomas-Reference-Cited by-同舟云学术

A mitotically active, cellular tumor stroma and/or inflammatory cells associated with tumor cells may contribute to intermediate or high Oncotype DX Recurrence Scores in low-grade invasive breast carcinomas

Published:2011-12-16 Issue:4 Volume:25 Page:556-566
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Acs Geza,Esposito Nicole N,Kiluk John,Loftus Loretta,Laronga Christine

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol2011194.pdf

Reference74 articles.

1. Simpson PT, Reis-Filho JS, Gale T, et al. Molecular evolution of breast cancer. J Pathol 2005;205:248–254.

2. Weigelt B, Reis-Filho JS . Histological and molecular types of breast cancer: is there a unifying taxonomy? Nat Rev Clin Oncol 2009;6:718–730.

3. Weigelt B, Baehner FL, Reis-Filho JS . The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade. J Pathol 2010;220:263–280.

4. Azzopardi JG, Ahmed A, Millis RR . Problems in Breast Pathology. WB Saunders: London, 1979.

5. Page DL, Anderson TJ . Diagnostic Histopathology of the Breast. Churchill Livingstone: Edinburgh, 1987.

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of reactive changes on multigene testing: histopathologic analysis of low-grade breast cancers with high-risk 21-gene recurrence scores;Breast Cancer Research and Treatment;2023-09-28

2. The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX® Testing;Cancers;2023-01-31

3. Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up;BMC Cancer;2022-11-25

4. Use of a supervised machine learning model to predict Oncotype DX risk category in node-positive patients older than 50 years of age;Breast Cancer Research and Treatment;2022-10-21

5. The Story of the Magee Equations: The Ultimate in Applied Immunohistochemistry;Applied Immunohistochemistry & Molecular Morphology;2022-09-21